AVITA Medical shareholders approve amended incentive plan, increase share reserve by 2.5M

AVITA Medical, Inc.

Amended 2020 Omnibus Incentive Plan approved, increasing share reserve by 2.5M to 6.75M shares.
All seven director nominees elected; for-votes ranged from 8.6M to 10.0M across candidates.
Ratified Grant Thornton as independent auditor for FY2025 with 13.4M votes for.
Approved grants to each of six non-executive directors: 10,022 RSUs and 4,295 options each.
Approved grant of options to acquire 520,000 shares to CEO James Corbett.

item 5.02item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.